Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471516) titled 'Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia' on March 3.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Condition: Congenital Dyserythropoietic Anemia (CDA)

Intervention: Drug: zoledronic acid

Recruitment Status: Recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: February 25, 2026

Target Sample Size: 2

Countries of Recruitment: China

To know more, visit https://clinicaltrial...